Found 7 matching trials
EBOla Post-Exposure Prophylaxis
PHASE3EBO-PEP is a multicentre, multi-epidemic, phase III, comparative, controlle...
Location
National Institute for Biomedical Research (INRB)
Immunology of Ebola Vaccine
PHASE2In this study 30 healthy adult participants will receive a single dose of a...
Status
Active Not Recruiting
Location
The Hope Clinic of the Emory Vaccine Center
Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure
PHASE3This study is a multi-center, open label, randomized phase 3b trial to asse...
Location
University Hospital Frankfurt (KGU)
Prophylaxis Vaccine Antibodies Ebola
PHASE2* Three measures are currently being implemented to control Ebola outbreaks...
Location
Centre de Traitement Ebola de N'Zerekore
A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects
PHASE1A Phase 1 Study to Evaluate the Safety and Immunogenicity of rVSV-Nipah Vir...
Location
Johnson County Clin-Trials(JCCT)
Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSVāG-ZEBOV-GP Vaccine)
PHASE2Background:
The Ebola virus causes a severe disease that can be fatal. The...
Location
The Hope Clinic of the Emory Vaccine Center, Emory University
Safety and Immunogenicity of rVSVĪG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses
PHASE4Concurrent vaccination scheduling for key target populations in Rwanda, suc...
Location
Multiple Locations